Glaukos Corporation
$10.8M 11,456 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Alafair Biosciences, Inc.
Alafair Biosciences, Inc. reported $10,781,868.25 across General Payments, Research, and Ownership to 704 physicians and teaching hospitals across 732 transactions.
- $10.8M
- All-tracks total
- 732
- Transactions
- 704
- Recipients
- +$61.7K
- General Payments vs PY2023
Alafair Biosciences, Inc. reported $10,781,868.25 across all CMS Open Payments tracks (General + Research + Ownership) to 704 physicians and teaching hospitals in Program Year 2024 - ranking #160 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $231,706.25, averaging $15.3K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer alafair-biosciences-inc Alafair Biosciences, Inc.
$10.8M · #160/1,925 · 0.1% industry · PY2024
- TOT $10.8M
- RANK #160
- SHARE 0.1%
- TXN 732
- RCP 704
- CAT 4
- GEN $231.7K
- ΔGEN +$61.7K
- TOP1 52.8%
- PY 2024
Volume peers
Nearest volume peer: Glaukos Corporation ($10.8M)
Alafair Biosciences, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Alafair Biosciences, Inc.'s CMS-reported General Payments increased by $61.7K (+36.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ALAFAIR BIOSCIENCES, INC.PY2023: ALAFAIR BIOSCIENCES, INC.PY2024: Alafair Biosciences, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $170,030.46
- PY2024
- $231,706.25
What the Data Shows for Alafair Biosciences, Inc.
In Program Year 2024, Alafair Biosciences, Inc. reported $10,781,868.25 in payments to 704 physicians and teaching hospitals across 732 individual transactions, an average of $14.7K per transaction and $15.3K per recipient. That total places Alafair Biosciences, Inc. at rank #160 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.1% slice of all industry payments reported nationwide for the year.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $125.0K, accounting for 53.9% of this company's General Payments and 13 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Alafair Biosciences, Inc.'s 4-category general-payment breakdown at $125.0K, 53.9% of the reported total.
Alafair Biosciences, Inc. reports 4 general-payment categories - the top three are Consulting Fee (53.9%), Food and Beverage (25.9%), and Compensation for Services Other Than Consulting (14.6%). The remaining 1 category make up 5.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Alafair Biosciences, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $125.0K | 13 | 53.9% |
| Food and Beverage | $59.9K | 639 | 25.9% |
| Compensation for Services Other Than Consulting | $33.8K | 20 | 14.6% |
| Travel and Lodging | $13.0K | 32 | 5.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $156,541.32 (67.6%) of $231,706.25 in this company's General Payments records across 452 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Alafair Biosciences, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Daniel Peterson
$122,267.12 across 46 reported transactions
- 2
Eric Giza
$13,037.45 across 10 reported transactions
- 3
Bauback Safa
$11,046.09 across 10 reported transactions
- 4
Walter Lin
$5,929.53 across 13 reported transactions
- 5
Robert Johnson
$4,261.13 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Alafair Biosciences, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Alafair Biosciences, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Alafair Biosciences, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Mesh Suture Inc
$10.8M 86 recipients
Compare payment profiles
TG Therapeutics, Inc.
$10.7M 12,185 recipients
Compare payment profiles
Ortho-Clinical Diagnostics, Inc.
$10.7M 232 recipients
Compare payment profiles
Sanofi-Aventis U.s. LLC
$10.7M 42,061 recipients
Compare payment profiles
Lexicon Pharmaceuticals, Inc.
$10.7M 20,498 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.